Therefore, we hypothesized that the ferroptosis during the progression of COVID-19 and NAFLD might be regulated through the CYBB-hsa-miR-196a/b-5p-TUG1 axis. The gene discussed is CYBB; the disease is metabolic dysfunction-associated steatotic liver disease.